1-3 of 3
Rogier Kersseboom
Close
Sort by
Journal Articles

ANKRD26 -related thrombocytopenia and myeloid malignancies

Patrizia Noris, Remi Favier, Marie-Christine Alessi, Amy E. Geddis, Shinji Kunishima, Paula G. Heller, Paola Giordano, Karen Y. Niederhoffer, James B. Bussel, Gian Marco Podda, Nicola Vianelli, Rogier Kersseboom, Alessandro Pecci, Chiara Gnan, Caterina Marconi, Anne Auvrignon, William Cohen, Jennifer C. Yu, Akihiro Iguchi, Allison Miller Imahiyerobo, Francoise Boehlen, Dorsaf Ghalloussi, Daniela De Rocco, Pamela Magini, Elisa Civaschi, Ginevra Biino, Marco Seri, Anna Savoia, Carlo L. Balduini
Journal: Blood
Blood (2013) 122 (11): 1987–1989.
https://doi.org/10.1182/blood-2013-04-499319
Published: 2013
Journal Articles

Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway

Van B. T. Ta, Marjolein J. W. de Bruijn, Petra J. ter Brugge, Jan Piet van Hamburg, Hans J. A. Diepstraten, Pieter Fokko van Loo, Rogier Kersseboom, Rudi W. Hendriks
Journal: Blood
Blood (2010) 115 (7): 1385–1393.
https://doi.org/10.1182/blood-2009-05-222166
Published: 2010
Includes: Supplemental data
Journal Articles

Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity

Sabine Middendorp, A. J. Esther Zijlstra, Rogier Kersseboom, Gemma M. Dingjan, Hassan Jumaa, Rudolf W. Hendriks
Journal: Blood
Blood (2005) 105 (1): 259–265.
https://doi.org/10.1182/blood-2004-07-2708
Published: 2005